Stay updated on Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedFooter now shows Revision: v3.3.3. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAn entry for Revision: v3.3.2 was added to the history and Revision: v3.2.0 was removed. This reflects versioning updates rather than changes to study data or page content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding operating-status notice, including details about potential delays, NIH Clinical Center status, and links to cc.nih.gov and opm.gov, was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check58 days agoChange DetectedChanges are limited to updates in the Record History version list and do not affect core study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference10%

- Check94 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.2%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.